Multiple Sclerosis (MS) is an inflammatory, often progressive, and potentially disabling
disease of the central nervous system. Onset of disease is usually between the ages of 15 …

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system
characterized by exacerbations of neurological dysfunction due to inflammatory …

Multiple Sclerosis: a complex disease requiring sophisticated management Multiple
Sclerosis poses labyrinthine challenges. There is no blood test to rely on for diagnosis; …

Multiple sclerosis (MS) is one of the most common inflammatory neurological diseases
which leads to a highly heterogeneous set of symptoms and signs due to the differential …

Revised and updated second edition of Multiple Sclerosis and Related Disorders: Clinical
Guide to Diagnosis, Medical Management, and Rehabilitation, the only comprehensive but …

The Multiple Sclerosis International Foundation estimates that over 2.5 million people
worldwide have multiple sclerosis. Throughout developed countries, increased attention has …

In an era of ever greater specialization among health care providers, it has become
increasingly difficult to stay abreast of the latest developments of any one particular field …

We have entered a golden era in multiple sclerosis (MS) research. Two decades ago, our
understanding of the disease was largely descriptive and there were no approved therapies …

Multiple sclerosis is a chronic and often disabling disease of the nervous system, affecting
about 1 million people worldwide. Even though it has been known for over a hundred years …

Multiple sclerosis (MS) is the most common disabling neurologic condition in young adults
and imposes high financial and quality of life costs on patients, their families, and society …